Oral and Perioral Herpes Simplex Virus Infection Type I in a Five-month-old Infant: A Case Report

January 14, 2021 updated by: Ashwag Yagoub Aloyouny, Princess Nourah Bint Abdulrahman University
A five-month-old healthy girl who presented with painful herpetic gingivostomatitis and perioral vesicles.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators present the case of a five-month-old healthy girl who presented with painful herpetic gingivostomatitis and perioral vesicles. The investigators discuss the pathophysiology of primary herpes simplex virus infection and the effect of maternal antibodies on the infant's immune system. In addition, the investigators explain the diagnosis, management, and prognosis of herpes simplex virus infection in young infants.

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
      • Riyadh, Saudi Arabia
        • Princess Nourah Bint Abdulrahman University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

This is a case report study

Description

Inclusion Criteria:

  • Five-months-old infants or younger

Exclusion Criteria:

  • Six-months-old infants or older

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health condition
Time Frame: one week
Number of tests were performed and different drugs were administered
one week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Princess Nourah Bint Abdulrahman University

Investigators

  • Principal Investigator: Ashwag Y Aloyouny, Princess Nourah Bint Abdulrahman University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2017

Primary Completion (Actual)

October 19, 2017

Study Completion (Actual)

October 19, 2017

Study Registration Dates

First Submitted

January 13, 2021

First Submitted That Met QC Criteria

January 14, 2021

First Posted (Actual)

January 19, 2021

Study Record Updates

Last Update Posted (Actual)

January 19, 2021

Last Update Submitted That Met QC Criteria

January 14, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PrincessNBAU

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe